Title
Shakespeare's Hamlet versus Sumarokov's Gamlet: A CorpusBased Perspective,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
This book is about the possible distinctions between Shakespeares Hamlet and Sumarokovs Gamlet, with the higher focus on the formal aspects of the texts that could be easily located, extracted, quantified, computerized, and, at the same time, could contribute towards identifying the authors intentions, especially relating to the structural and lexical organisation of both plays. The research reported here adopts an original multipronged approach including quantitative, qualitative and comparative analyses. Key findings shed light on substantial divergences between Shakespeare and Sumarokovs perceptions of the main and secondary characters, of the complexity of their relationships as well as provide evidence to striking diversions between the playwrights religious, sociopolitical, family, moral, philosophical and artistic conceptual frameworks. This work should not only benefit research on corpus linguistics with respect to literary texts but also be of interest more generally to scholars of translation and comparative literature, deepening our understanding of translation and literary processes.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.